0001217234-21-000018.txt : 20210115 0001217234-21-000018.hdr.sgml : 20210115 20210115172105 ACCESSION NUMBER: 0001217234-21-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210114 FILED AS OF DATE: 20210115 DATE AS OF CHANGE: 20210115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King Sasha CENTRAL INDEX KEY: 0001721150 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36536 FILM NUMBER: 21533083 MAIL ADDRESS: STREET 1: C/O CAREDX, INC. STREET 2: 3260 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CareDx, Inc. CENTRAL INDEX KEY: 0001217234 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 943316839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 TOWER PLACE STREET 2: 9TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-287-2300 MAIL ADDRESS: STREET 1: 1 TOWER PLACE STREET 2: 9TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: XDx, Inc. DATE OF NAME CHANGE: 20071010 FORMER COMPANY: FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC DATE OF NAME CHANGE: 20030203 4 1 wf-form4_161074925300821.xml FORM 4 X0306 4 2021-01-14 0 0001217234 CareDx, Inc. CDNA 0001721150 King Sasha C/O CAREDX, INC. 1 TOWER PLACE, 9TH FLOOR SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Commercial Officer Common Stock 2021-01-14 4 M 0 833 1.07 A 44264 D Common Stock 2021-01-14 4 M 0 2500 5.90 A 46764 D Common Stock 2021-01-14 4 M 0 417 2.80 A 47181 D Common Stock 2021-01-14 4 M 0 750 1 A 47931 D Common Stock 2021-01-14 4 M 0 3125 12.24 A 51056 D Common Stock 2021-01-14 4 M 0 1250 6.31 A 52306 D Common Stock 2021-01-14 4 M 0 1000 27.17 A 53306 D Common Stock 2021-01-14 4 S 0 700 85.2372 D 52606 D Common Stock 2021-01-14 4 S 0 1400 86.4594 D 51206 D Common Stock 2021-01-14 4 S 0 2601 87.5623 D 48605 D Common Stock 2021-01-14 4 S 0 5174 88.1585 D 43431 D Employee Stock Option (right to buy) 1.07 2021-01-14 4 M 0 833 0 D 2027-06-09 Common Stock 833.0 1042 D Employee Stock Option (right to buy) 5.9 2021-01-14 4 M 0 2500 0 D 2027-10-27 Common Stock 2500.0 8333 D Employee Stock Option (right to buy) 2.8 2021-01-14 4 M 0 417 0 D 2027-09-01 Common Stock 417.0 1111 D Employee Stock Option (right to buy) 1.0 2021-01-14 4 M 0 750 0 D 2027-04-21 Common Stock 750.0 750 D Employee Stock Option (right to buy) 12.24 2021-01-14 4 M 0 3125 0 D 2028-06-29 Common Stock 3125.0 17708 D Employee Stock Option (right to buy) 6.31 2021-01-14 4 M 0 1250 0 D 2028-01-19 Common Stock 1250.0 5417 D Employee Stock Option (right to buy) 27.17 2021-01-14 4 M 0 1000 0 D 2029-02-04 Common Stock 1000.0 8333 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $84.76 to $85.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $85.99 to $86.915, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $87.06 to $88.03, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $88.06 to $88.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price. 25% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. 50% of the shares subject to the option vested on September 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. 25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. /s/ Peter Maag, as attorney-in-fact for Sasha King 2021-01-15